| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/07/2011 | CN101869562B 左旋氨氯地平复方药物制剂 Levamlodipine compound pharmaceutical preparations |
| 12/07/2011 | CN101812025B 吡嗪芳酸醚类化合物、制备方法和医药应用 Pyrazine aromatic acid ether compounds, preparation method and medical applications |
| 12/07/2011 | CN101804111B 治疗高血压的中药药物及其制备方法 Traditional Chinese medicine and its preparation method for the treatment of hypertension |
| 12/07/2011 | CN101791310B 长春西汀药物组合物及其制备方法 Vinpocetine pharmaceutical compositions and methods for preparing |
| 12/07/2011 | CN101773595B 清肝明目中药茶 Liver eyesight herbal tea |
| 12/07/2011 | CN101773517B H<sub>2</sub>S或H<sub>2</sub>S供体温度敏感性注射用即型凝胶制剂 H <sub> 2 </ sub> S or H <sub> 2 </ sub> S donor temperature-sensitive injectable gel formulations that |
| 12/07/2011 | CN101768153B 制备高血压治疗药物伊拉地平的方法 The method of preparation of the treatment of hypertension drug isradipine |
| 12/07/2011 | CN101744936B 一种颈复康制剂的检测方法 Detection method Jingfukang preparations |
| 12/07/2011 | CN101683337B 柯楠因在制备治疗心肌损伤性心脏病药物中的用途 Nan Ke use in the preparation of the treatment of myocardial damage due to heart medicine |
| 12/07/2011 | CN101642179B 一种具有降压、降糖、降脂的茶饮料 A kind of blood pressure, blood glucose, lipid-lowering tea |
| 12/07/2011 | CN101637455B 一种依替巴肽粉针剂 One kind of eptifibatide powder |
| 12/07/2011 | CN101570564B 一种丹参酮ⅱa丙烯酸的精制方法 The method of producing a purified acrylic Tan ⅱa |
| 12/07/2011 | CN101519444B 一种制备奈西利肽的方法 A method for preparing a peptide 奈西利 |
| 12/07/2011 | CN101406527B 延胡索总生物碱盐的制备方法及其作为治疗心血管疾病药物的应用 Preparation of total alkaloids salt thereof as drugs to treat cardiovascular disease |
| 12/07/2011 | CN101357117B 灯盏花素注射液及其制备方法 Breviscapine injection and its preparation method |
| 12/07/2011 | CN101352253B 羽衣甘蓝红枣山楂菊花复合饮料 Kale dates Hawthorn chrysanthemum compound beverage |
| 12/07/2011 | CN101278970B 东紫苏类黄酮的制备方法 Preparation East basil flavonoids |
| 12/07/2011 | CN101232901B 磺酰胺化合物和血管生成抑制物质的联合新应用 Sulfonamide compound and angiogenesis inhibitory substances combined new applications |
| 12/07/2011 | CN101164578B 一种治疗痔疮的中药组合物及其制备方法 Chinese medicinal composition and preparation method for the treatment of hemorrhoids |
| 12/07/2011 | CN101054344B 脂氧素A<sub>4</sub>类似物 Lipoxin A <sub> 4 </ sub> analogue |
| 12/07/2011 | CN101040906B 一种治疗心脑血管疾病的注射剂及其制备方法和质控方法 An injection preparation method and quality control method of treating cardiovascular disease |
| 12/06/2011 | US8071729 Anti-integrin antibodies, compositions, methods and uses |
| 12/06/2011 | US8071654 Inhibitors of thromboxane formation and action |
| 12/06/2011 | US8071635 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors; |
| 12/06/2011 | US8071621 Alkylsulphonamide quinolines |
| 12/06/2011 | US8071564 Regulation of angiogenesis with zinc finger proteins |
| 12/06/2011 | US8071549 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells |
| 12/06/2011 | US8071546 Uses of pegylated albumin |
| 12/06/2011 | US8071366 Neural progenitor cells derived from whole bone marrow |
| 12/06/2011 | US8071333 Anti-integrin antibodies, compositions, methods and uses |
| 12/06/2011 | US8071141 Compositions for preventing or ameliorating multiple risk factor syndromes |
| 12/06/2011 | US8071096 Anti-C5aR antibodies and uses thereof |
| 12/06/2011 | US8071091 Non-neurotoxic plasminogen activating factors for treating stroke |
| 12/06/2011 | CA2491317C Modafinil pharmaceutical compositions |
| 12/06/2011 | CA2455620C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/06/2011 | CA2383522C Neurotherapeutic composition and method |
| 12/01/2011 | WO2011150347A2 Non-peptide bdnf neurotrophin mimetics |
| 12/01/2011 | WO2011150299A2 Treatment of myocardial infarction and vascular injury with netrin-1 |
| 12/01/2011 | WO2011149981A2 Oral formulations for counteracting effects of aging |
| 12/01/2011 | WO2011149964A2 Methods for treating or preventing vascular graft failure |
| 12/01/2011 | WO2011149862A1 Nicotinic receptor non-competitive antagonists modulators |
| 12/01/2011 | WO2011149859A1 Nicotinic receptor non-competitive antagonists |
| 12/01/2011 | WO2011149601A1 Treatment of vagally- mediated spectrum disorders with 5ht3 antagonists |
| 12/01/2011 | WO2011149438A1 Combination of antihypertensive agents |
| 12/01/2011 | WO2011149206A2 Pharmaceutical composition containing crystalline nebivolol hydrochloride and method for preparing the same |
| 12/01/2011 | WO2011149110A1 Novel composition for the prevention and/or treatment of thromboembolism |
| 12/01/2011 | WO2011149016A1 Complex containing thrombolytic enzyme |
| 12/01/2011 | WO2011149011A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 12/01/2011 | WO2011148956A1 Fused imidazole derivative |
| 12/01/2011 | WO2011148922A1 Novel quinazoline compound |
| 12/01/2011 | WO2011148640A1 Blood flow promoter and external preparation |
| 12/01/2011 | WO2011148208A1 8-hydroxy-quinoline derivatives |
| 12/01/2011 | WO2011148014A1 Use of oxaloacetate in the treatment of ischaemia |
| 12/01/2011 | WO2011147989A1 Process for the preparation of an enriched extract from grape vine plant leaves |
| 12/01/2011 | WO2011147810A1 THE USE OF sGC STIMULATORS, sGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS (SSc). |
| 12/01/2011 | WO2011147809A1 Substituted 5-fluoro-1h-pyrazolopyridines and use thereof |
| 12/01/2011 | WO2011147588A1 Compositions for use in genetic disorders comprising 4-phenyl- butyric acid and its salts |
| 12/01/2011 | WO2011147587A1 Compositions for use in cardiovascular diseases comprising 4 - phenyl - butyric acid and its salts |
| 12/01/2011 | WO2011147586A1 Compositions for use in neurological or neurodegenerative diseases with a genetic disorder background comprising 4-phenyl-butyric acid and its salts |
| 12/01/2011 | WO2011147584A1 Compositions for use in genetic disorders causative for cystic fibrosis comprising 4-phenyl-butyric acid and its salts |
| 12/01/2011 | WO2011147528A1 Biguanide compounds and its use for treating cancer |
| 12/01/2011 | WO2011147086A1 Microvesicles carrying small interfering rnas, preparation methods and uses thereof |
| 12/01/2011 | WO2011126842A3 Targeting micrornas for the treatment of cardiac disorders |
| 12/01/2011 | WO2010146551A3 Orally disintegrating compositions comprising antihypertensive agents |
| 12/01/2011 | US20110295225 Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
| 12/01/2011 | US20110294902 Pharmaceutical compositions providing enhanced drug concentrations |
| 12/01/2011 | US20110294884 Bipolar trans carotenoid salts and their uses |
| 12/01/2011 | US20110294883 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
| 12/01/2011 | US20110294878 Inhibitors of Dimethylarginine Dimethylaminohydrolase |
| 12/01/2011 | US20110294875 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/01/2011 | US20110294874 Diagnosis and therapy of organ dysfunction using sphinganine-1-phosphate |
| 12/01/2011 | US20110294870 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene |
| 12/01/2011 | US20110294868 Modulation of transthyretin expression |
| 12/01/2011 | US20110294862 Treatment or prevention of hypotension and shock |
| 12/01/2011 | US20110294860 Aqueous oral preparation of stable amlodipine |
| 12/01/2011 | US20110294859 Substituted pyridoxine-lactam carboxylate salts |
| 12/01/2011 | US20110294856 Novel oxadiazole derivatives and their medical use |
| 12/01/2011 | US20110294854 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS |
| 12/01/2011 | US20110294849 Aminopyrazole triazolothiadiazole inhibitor of c-met protein kinase |
| 12/01/2011 | US20110294833 Methods for Healthy Aging |
| 12/01/2011 | US20110294832 Fused ring compound and use thereof |
| 12/01/2011 | US20110294825 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/01/2011 | US20110294824 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/01/2011 | US20110294820 N-Oxides of n-Phenyl-2-pyrimidine-amine Derivatives |
| 12/01/2011 | US20110294815 Prostacyclin analogs |
| 12/01/2011 | US20110294809 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
| 12/01/2011 | US20110294808 Indazole Compounds As CCR1 Receptor Antagonists |
| 12/01/2011 | US20110294807 Compounds for the prevention and treatment of cardiovascular disease |
| 12/01/2011 | US20110294796 Benzotriazine inhibitors of kinases |
| 12/01/2011 | US20110294794 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 12/01/2011 | US20110294788 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 12/01/2011 | US20110294784 Gamma secretase modulators |
| 12/01/2011 | US20110294781 Pyrazolo-pyrimidine compounds |
| 12/01/2011 | US20110294780 SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS |
| 12/01/2011 | US20110294752 Triterpene compositions and methods for use thereof |
| 12/01/2011 | US20110294746 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules |
| 12/01/2011 | US20110294734 Pharmaceutical compositions comprising tgf-beta 1 inhibitor peptides |
| 12/01/2011 | US20110294719 Dipeptoid prodrugs and the use thereof |
| 12/01/2011 | US20110294718 Dipeptoid prodrugs and the use thereof |
| 12/01/2011 | US20110294665 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |